159 related articles for article (PubMed ID: 33105692)
1. In Cellulo Evaluation of the Therapeutic Potential of NHC Platinum Compounds in Metastatic Cutaneous Melanoma.
Charignon E; Bouché M; Clave-Darcissac C; Dahm G; Ichim G; Clotagatide A; Mertani HC; Telouk P; Caramel J; Diaz JJ; Bellemin-Laponnaz S; Bouvet P; Billotey C
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105692
[TBL] [Abstract][Full Text] [Related]
2. Exploring diversity in platinum(iv) N-heterocyclic carbene complexes: synthesis, characterization, reactivity and biological evaluation.
Bouché M; Bonnefont A; Achard T; Bellemin-Laponnaz S
Dalton Trans; 2018 Aug; 47(33):11491-11502. PubMed ID: 30074048
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of ABCB5 in BRAF inhibitor-resistant melanoma cell lines.
Xiao J; Egger ME; McMasters KM; Hao H
BMC Cancer; 2018 Jun; 18(1):675. PubMed ID: 29929490
[TBL] [Abstract][Full Text] [Related]
4.
Bouché M; Vincent B; Achard T; Bellemin-Laponnaz S
Molecules; 2020 Jul; 25(14):. PubMed ID: 32660104
[TBL] [Abstract][Full Text] [Related]
5. Preclinical evaluation of the imipridone family, analogs of clinical stage anti-cancer small molecule ONC201, reveals potent anti-cancer effects of ONC212.
Wagner J; Kline CL; Ralff MD; Lev A; Lulla A; Zhou L; Olson GL; Nallaganchu BR; Benes CH; Allen JE; Prabhu VV; Stogniew M; Oster W; El-Deiry WS
Cell Cycle; 2017 Oct; 16(19):1790-1799. PubMed ID: 28489985
[TBL] [Abstract][Full Text] [Related]
6. Novel cis-[(NHC)
Rehm T; Rothemund M; Muenzner JK; Noor A; Kempe R; Schobert R
Dalton Trans; 2016 Oct; 45(39):15390-15398. PubMed ID: 27603959
[TBL] [Abstract][Full Text] [Related]
7. The anticancer activity of an air-stable Pd(I)-NHC (NHC = N-heterocyclic carbene) dimer.
Scattolin T; Bortolamiol E; Palazzolo S; Caligiuri I; Perin T; Canzonieri V; Demitri N; Rizzolio F; Cavallo L; Dereli B; Mane MV; Nolan SP; Visentin F
Chem Commun (Camb); 2020 Oct; 56(81):12238-12241. PubMed ID: 32926011
[TBL] [Abstract][Full Text] [Related]
8. Concentration-Dependent Dual Effects of Ciprofloxacin on SB-590885-Resistant BRAF
Aldaghi SA; Jalal R
Chem Res Toxicol; 2019 Apr; 32(4):645-658. PubMed ID: 30829029
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of ester- and amide-functionalized imidazolium salts and related water-soluble coinage metal N-heterocyclic carbene complexes.
Pellei M; Gandin V; Marinelli M; Marzano C; Yousufuddin M; Dias HV; Santini C
Inorg Chem; 2012 Sep; 51(18):9873-82. PubMed ID: 22946642
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of the selective pan-RAF inhibitor TAK-632 in BRAF inhibitor-resistant melanoma.
Nakamura A; Arita T; Tsuchiya S; Donelan J; Chouitar J; Carideo E; Galvin K; Okaniwa M; Ishikawa T; Yoshida S
Cancer Res; 2013 Dec; 73(23):7043-55. PubMed ID: 24121489
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic added value of a trans-Sulfonamide-Platinum-Complex in human melanoma cell lines and synergism with cis-Platin.
Agudo-López A; Prieto-García E; Alemán J; Pérez C; Díaz-García CV; Parrilla-Rubio L; Cabrera S; Navarro-Ranninger C; Cortés-Funes H; López-Martín JA; Agulló-Ortuño MT
Mol Cancer; 2017 Feb; 16(1):45. PubMed ID: 28231799
[TBL] [Abstract][Full Text] [Related]
12. Platinum(ii) O,S complexes as potential metallodrugs against Cisplatin resistance.
Hildebrandt J; Häfner N; Görls H; Kritsch D; Ferraro G; Dürst M; Runnebaum IB; Merlino A; Weigand W
Dalton Trans; 2016 Nov; 45(47):18876-18891. PubMed ID: 27897281
[TBL] [Abstract][Full Text] [Related]
13. ER stress promotes antitumor effects in BRAFi/MEKi resistant human melanoma induced by natural compound 4-nerolidylcathecol (4-NC).
Alves-Fernandes DK; Oliveira ÉA; Faião-Flores F; Alicea-Rebecca G; Weeraratna AT; Smalley KSM; Barros SBM; Maria-Engler SS
Pharmacol Res; 2019 Mar; 141():63-72. PubMed ID: 30550954
[TBL] [Abstract][Full Text] [Related]
14. The first small molecules capable of strongly suppressing proliferation of cancer cells harboring BRAF class I/II/III mutations.
Choi SH; Shin I; Kim N; Nam Y; Sim T
Biochem Biophys Res Commun; 2020 Nov; 532(2):315-320. PubMed ID: 32873393
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial complex I inhibitor deguelin induces metabolic reprogramming and sensitizes vemurafenib-resistant BRAF
Carpenter EL; Chagani S; Nelson D; Cassidy PB; Laws M; Ganguli-Indra G; Indra AK
Mol Carcinog; 2019 Sep; 58(9):1680-1690. PubMed ID: 31211467
[TBL] [Abstract][Full Text] [Related]
16. Oxidative DNA double strand breaks and autophagy in the antitumor effect of sterically hindered platinum(II) complexes in NSCLCs.
Chen F; Wang X; Jin X; Zhao J; Gou S
Oncotarget; 2017 May; 8(19):30933-30955. PubMed ID: 28427237
[TBL] [Abstract][Full Text] [Related]
17. Vemurafenib: a guide to its use in unresectable or metastatic melanoma.
Keating GM; Lyseng-Williamson KA
Am J Clin Dermatol; 2013 Feb; 14(1):65-9. PubMed ID: 23329082
[TBL] [Abstract][Full Text] [Related]
18. Chelating Phosphine-N-Heterocyclic Carbene Platinum Complexes via Catalytic Asymmetric Hydrophosphination and Their Cytotoxicity Toward MKN74 and MCF7 Cancer Cell Lines.
Seah JWK; Lee JXT; Li Y; Pullarkat SA; Tan NS; Leung PH
Inorg Chem; 2021 Nov; 60(22):17276-17287. PubMed ID: 34709031
[TBL] [Abstract][Full Text] [Related]
19. Fasting boosts sensitivity of human skin melanoma to cisplatin-induced cell death.
Antunes F; Corazzari M; Pereira G; Fimia GM; Piacentini M; Smaili S
Biochem Biophys Res Commun; 2017 Mar; 485(1):16-22. PubMed ID: 27693581
[TBL] [Abstract][Full Text] [Related]
20. Targeting signal-transducer-and-activator-of-transcription 3 sensitizes human cutaneous melanoma cells to BRAF inhibitor.
Wang X; Qu H; Dong Y; Wang G; Zhen Y; Zhang L
Cancer Biomark; 2018; 23(1):67-77. PubMed ID: 30010109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
